<DOC>
	<DOCNO>NCT00005649</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness paclitaxel capecitabine treat woman metastatic breast cancer .</brief_summary>
	<brief_title>Paclitaxel Capecitabine Treating Women With Metastatic Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine safety , response rate , efficacy combination therapy paclitaxel capecitabine first second line therapy woman metastatic breast cancer . OUTLINE : This multicenter study . Patients receive paclitaxel IV 3 hour day 1 capecitabine orally twice daily day 1-14 . Treatment repeat every 21 day absence disease progression unacceptable toxicity . Patients follow survival status every 3 month upon completion treatment . PROJECTED ACCRUAL : A total 60 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm metastatic breast cancer Bidimensionally measurable disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 75 Sex : Female Menopausal status : Not specify Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : ANC least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 1.5 time upper limit normal ( ULN ) Renal : Creatinine le 1.5 time ULN Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Eligible patient may receive prior chemotherapy metastatic adjuvant set following exception : At least 12 month since prior fluoropyrimidine therapy At least 12 month since prior taxane therapy Only 1 previous chemotherapeutic regimen metastatic set Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
</DOC>